The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Bristol-Myers Squibb; Janssen; Novartis
Research Funding - Bayer; BMS Brazil; Exelixis; Janssen; MedImmune; Merck KGaA; MSD; Nektar; Novartis; Pfizer; Roche
Phase II trial of induction chemotherapy plus chemoradiotherapy with aspirin or placebo in high-risk rectal cancer (ICAR).
 
Juliana Souza
No Relationships to Disclose
 
Rodrigo Otavio Araujo
No Relationships to Disclose
 
Marcus Valadão
No Relationships to Disclose
 
Victor Marcondes Lopes Santos
No Relationships to Disclose
 
Jamille Gonzaga
No Relationships to Disclose
 
Monica Luciana Agostinho Padoan
No Relationships to Disclose
 
Monique Alvares Barbosa
No Relationships to Disclose
 
Claudia Torres
No Relationships to Disclose
 
Raquel Guimarães
No Relationships to Disclose
 
Juliana Carvalho
No Relationships to Disclose
 
Roberto de Almeida Gil
No Relationships to Disclose
 
Isabele Small
No Relationships to Disclose
 
Maria Aparecida Ferreira
No Relationships to Disclose
 
João Pedro Araujo Simões Correa
No Relationships to Disclose
 
Ivanir Martins Oliveira
No Relationships to Disclose
 
Eduardo Linhares Rielo Mello
No Relationships to Disclose
 
Andreia Cristina De Melo
Honoraria - BMS Brazil; MSD Oncology; Novartis
Consulting or Advisory Role - Roche
Speakers' Bureau - BMS Brazil; MSD Oncology
Research Funding - BMS Brazil (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Luiz H. Araujo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Grupo Pardini; Merck; Merck Sharp & Dohme; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst)